The United Laboratories International (HKG:3933) said its generic antibiotic drug passed the consistency evaluation for generic drugs in China, according to a Hong Kong bourse filing Thursday.
Shares of the pharmaceutical products company fell nearly 7% in morning trade Friday.
The company had sought approval for its amoxicillin sodium and clavulanate potassium injection, which was cleared by China's National Medical Products Administration.